VILOXAZINE HYDROCHLORIDE

VILOXAZINE HYDROCHLORIDE was reported 1309 times

VILOXAZINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANOGENITAL LICHEN PLANUS 1 0.0667
1 CONGENITAL MYASTHENIC SYNDROME 1 0.0476
2 MICROSLEEP 1 0.0250
3 DERMAL ABSORPTION INCREASED 1 0.0244
4 URINE CALCIUM 1 0.0189
5 POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE II 1 0.0185
6 SLEEP SEX 1 0.0167
7 PLASMA CELLS INCREASED 1 0.0137
8 FIGHT IN SCHOOL 1 0.0135
9 DISRUPTIVE MOOD DYSREGULATION DISORDER 1 0.0135
10 URINE AMPHETAMINE POSITIVE 4 0.0122
11 HUMAN BITE 1 0.0120
12 PULMONARY HISTOPLASMOSIS 1 0.0100
13 SKIN ODOUR ABNORMAL 36 0.0091
14 SEPARATION ANXIETY DISORDER 1 0.0084
15 SCHIZOPHRENIA, PARANOID TYPE 3 0.0083
16 BRIEF RESOLVED UNEXPLAINED EVENT 1 0.0076
17 SPECIFIC GRAVITY URINE INCREASED 1 0.0075
18 TONSILLOLITH 1 0.0071
19 HYPERACTIVE PHARYNGEAL REFLEX 1 0.0069
20 AMPHETAMINES POSITIVE 5 0.0067
21 CYCLOTHYMIC DISORDER 1 0.0061
22 CENTRAL NERVOUS SYSTEM STIMULATION 1 0.0056
23 OPPOSITIONAL DEFIANT DISORDER 2 0.0051
24 DRUG WITHDRAWAL HEADACHE 2 0.0048
25 EXPOSURE VIA INHALATION 1 0.0046
26 PRODUCT CONTAMINATION CHEMICAL 1 0.0046
27 SUBSTANCE ABUSER 1 0.0044
28 CREST SYNDROME 1 0.0042
29 AUTOPHOBIA 1 0.0039
30 ONYCHOPHAGIA 1 0.0036
31 MERYCISM 1 0.0035
32 REGRESSIVE BEHAVIOUR 1 0.0034
33 THYROIDITIS SUBACUTE 1 0.0034
34 SLEEP PARALYSIS 5 0.0034
35 MIGRAINE WITHOUT AURA 1 0.0033
36 DEFIANT BEHAVIOUR 1 0.0032
37 VASCULAR COMPRESSION 1 0.0032
38 SEASONAL AFFECTIVE DISORDER 1 0.0032
39 PRESSURE OF SPEECH 2 0.0031
40 OXYGEN SATURATION INCREASED 1 0.0029
41 PHYSICAL EXAMINATION ABNORMAL 1 0.0026
42 SUICIDE THREAT 1 0.0026
43 DISEASE RISK FACTOR 1 0.0025
44 REACTION TO COLOURING 1 0.0024
45 SUICIDAL BEHAVIOUR 10 0.0024
46 SELF-INJURIOUS IDEATION 10 0.0024
47 ATTENTION DEFICIT HYPERACTIVITY DISORDER 10 0.0024
48 SOLILOQUY 2 0.0023
49 SELF-DESTRUCTIVE BEHAVIOUR 2 0.0023
50 REFLUX LARYNGITIS 1 0.0023
51 TERMINAL INSOMNIA 4 0.0023
52 HAEMORRHOID OPERATION 1 0.0022
53 DELUSION OF GRANDEUR 1 0.0022
54 PHONOPHOBIA 1 0.0022
55 SEXUALLY INAPPROPRIATE BEHAVIOUR 1 0.0021
56 WOLFF-PARKINSON-WHITE SYNDROME 1 0.0021
57 PATIENT UNCOOPERATIVE 1 0.0021
58 BLOOD ALKALINE PHOSPHATASE DECREASED 2 0.0021
59 HOMICIDAL IDEATION 8 0.0020
60 HYPERMETABOLISM 1 0.0019
61 EXECUTIVE DYSFUNCTION 1 0.0018
62 NEAR DEATH EXPERIENCE 6 0.0018
63 TRICHOTILLOMANIA 1 0.0017
64 INTRUSIVE THOUGHTS 2 0.0017
65 DERMATILLOMANIA 1 0.0017
66 PALATAL DISORDER 1 0.0017
67 SACRAL PAIN 1 0.0016
68 THYROXINE DECREASED 1 0.0016
69 SPONTANEOUS PENILE ERECTION 1 0.0016
70 IMPULSIVE BEHAVIOUR 6 0.0016
71 MANIA 26 0.0016
72 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
73 SOCIAL ANXIETY DISORDER 1 0.0015
74 HALLUCINATION, TACTILE 1 0.0015
75 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
76 IMPULSE-CONTROL DISORDER 3 0.0015
77 TACHYPHRENIA 5 0.0014
78 PHYSICAL ASSAULT 3 0.0014
79 NONINFECTIVE ENCEPHALITIS 1 0.0014
80 DISSOCIATIVE DISORDER 1 0.0014
81 BITE 1 0.0014
82 LABELLED DRUG-DRUG INTERACTION ISSUE 2 0.0014
83 WITHDRAWAL BLEED 1 0.0014
84 WITHDRAWAL SYNDROME 57 0.0014
85 BLUNTED AFFECT 1 0.0014
86 HYPERACUSIS 5 0.0013
87 INDIFFERENCE 1 0.0013
88 ANGER 44 0.0013
89 MIGRAINE 124 0.0013
90 EYELID FUNCTION DISORDER 1 0.0013
91 ORGASM ABNORMAL 1 0.0012
92 BREATH ODOUR 3 0.0012
93 EDUCATIONAL PROBLEM 2 0.0012
94 INITIAL INSOMNIA 12 0.0012
95 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 1 0.0011
96 TIC 6 0.0011
97 PRODUCT AFTER TASTE 1 0.0010
98 VOMITING PROJECTILE 3 0.0010
99 NEGATIVE THOUGHTS 3 0.0010
100 ENERGY INCREASED 6 0.0010
101 ANTISOCIAL BEHAVIOUR 1 0.0010
102 THYROID HORMONES INCREASED 1 0.0010
103 TORTICOLLIS 2 0.0009
104 BIPOLAR I DISORDER 2 0.0009
105 MIDDLE EAR EFFUSION 2 0.0009
106 SUICIDAL IDEATION 82 0.0009
107 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
108 MOANING 1 0.0009
109 METABOLIC SURGERY 1 0.0009
110 MENOPAUSAL SYMPTOMS 2 0.0009
111 MORBID THOUGHTS 1 0.0009
112 FEELING OF BODY TEMPERATURE CHANGE 5 0.0009
113 WRONG DOSE 2 0.0008
114 HYPOMANIA 3 0.0008
115 POST-ACUTE COVID-19 SYNDROME 1 0.0008
116 VASODILATATION 2 0.0008
117 YAWNING 2 0.0007
118 PRODUCT SIZE ISSUE 4 0.0007
119 GAMBLING DISORDER 2 0.0007
120 IRRITABILITY 44 0.0007
121 AFFECT LABILITY 7 0.0007
122 DROOLING 5 0.0007
123 INSURANCE ISSUE 11 0.0007
124 ERECTION INCREASED 3 0.0007
125 ELECTRIC SHOCK SENSATION 2 0.0007
126 MAST CELL ACTIVATION SYNDROME 1 0.0007
127 SLEEP TERROR 3 0.0007
128 AUDITORY DISORDER 1 0.0007
129 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
130 ANKLE OPERATION 1 0.0007
131 CONJUNCTIVITIS ALLERGIC 1 0.0007
132 SKIN STRIAE 1 0.0007
133 GASTRITIS HAEMORRHAGIC 1 0.0007
134 DISSOCIATION 5 0.0007
135 FEELING OF DESPAIR 3 0.0006
136 MIDDLE INSOMNIA 12 0.0006
137 TRANSCRIPTION MEDICATION ERROR 1 0.0006
138 PRODUCT USE COMPLAINT 10 0.0006
139 INAPPROPRIATE AFFECT 1 0.0006
140 AGGRESSION 31 0.0006
141 SHOULDER FRACTURE 1 0.0006
142 DENTAL IMPLANTATION 1 0.0006
143 THERAPY CHANGE 6 0.0006
144 IMPAIRED WORK ABILITY 13 0.0006
145 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
146 MENSTRUAL DISORDER 5 0.0006
147 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
148 SLEEP TALKING 1 0.0006
149 SKIN WOUND 1 0.0006
150 EYE MOVEMENT DISORDER 4 0.0006
151 TONGUE COATED 1 0.0006
152 CATATONIA 3 0.0006
153 EMOTIONAL POVERTY 1 0.0006
154 PRODUCT COMMUNICATION ISSUE 5 0.0006
155 HALLUCINATION, AUDITORY 9 0.0006
156 PRODUCT DOSE OMISSION IN ERROR 16 0.0006
157 RETCHING 12 0.0006
158 SCHIZOAFFECTIVE DISORDER 1 0.0006
159 BEHAVIOUR DISORDER 3 0.0006
160 ESSENTIAL HYPERTENSION 1 0.0005
161 PUPILLARY REFLEX IMPAIRED 1 0.0005
162 HEART RATE ABNORMAL 3 0.0005
163 LYMPH NODE PAIN 1 0.0005
164 TUNNEL VISION 1 0.0005
165 LIVING IN RESIDENTIAL INSTITUTION 1 0.0005
166 PHOTOPHOBIA 10 0.0005
167 CRYING 19 0.0005
168 NIGHTMARE 18 0.0005
169 CONVERSION DISORDER 1 0.0005
170 NASAL SEPTUM DEVIATION 1 0.0005
171 UNDERWEIGHT 1 0.0005
172 INABILITY TO AFFORD MEDICATION 5 0.0005
173 ENURESIS 2 0.0005
174 LIBIDO INCREASED 1 0.0005
175 EYELID PAIN 1 0.0005
176 SELF-MEDICATION 2 0.0005
177 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
178 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
179 HALLUCINATIONS, MIXED 2 0.0005
180 MOOD SWINGS 15 0.0005
181 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
182 THERAPY CESSATION 24 0.0005
183 PANIC ATTACK 17 0.0005
184 TEARFULNESS 2 0.0005
185 OLIGOMENORRHOEA 1 0.0005
186 CORNEAL DISORDER 1 0.0005
187 DELUSION 7 0.0005
188 FEAR OF DEATH 1 0.0004
189 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
190 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
191 REACTION TO EXCIPIENT 1 0.0004
192 SOMNOLENCE 87 0.0004
193 FLAT AFFECT 1 0.0004
194 RENAL FUNCTION TEST ABNORMAL 2 0.0004
195 DISTURBANCE IN SOCIAL BEHAVIOUR 1 0.0004
196 DYSMORPHISM 1 0.0004
197 EMOTIONAL DISORDER 13 0.0004
198 EOSINOPHIL COUNT DECREASED 1 0.0004
199 FEELING JITTERY 8 0.0004
200 URINARY HESITATION 1 0.0004
201 SEROTONIN SYNDROME 8 0.0004
202 APATHY 6 0.0004
203 INSOMNIA 109 0.0004
204 PARANOIA 7 0.0004
205 ABNORMAL BEHAVIOUR 16 0.0004
206 ADVERSE EVENT 36 0.0004
207 ABNORMAL UTERINE BLEEDING 1 0.0004
208 MENOPAUSE 1 0.0004
209 DRUG TITRATION ERROR 1 0.0004
210 CATHETER SITE PAIN 1 0.0004
211 AFFECTIVE DISORDER 3 0.0004
212 CYANOSIS 6 0.0004
213 PRODUCT RESIDUE PRESENT 2 0.0004
214 SKIN DISCOMFORT 1 0.0004
215 EAR CONGESTION 1 0.0004
216 ABDOMINAL RIGIDITY 1 0.0004
217 MIGRAINE WITH AURA 1 0.0004
218 NONSPECIFIC REACTION 2 0.0004
219 CYSTIC FIBROSIS 2 0.0004
220 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
221 AGITATION 26 0.0004
222 CEREBRAL THROMBOSIS 1 0.0004
223 THERAPY INTERRUPTED 25 0.0003
224 HYPERTONIC BLADDER 1 0.0003
225 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
226 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
227 HYPERVENTILATION 2 0.0003
228 URINE ODOUR ABNORMAL 2 0.0003
229 URINE ANALYSIS ABNORMAL 1 0.0003
230 HEART RATE INCREASED 33 0.0003
231 LOSS OF EMPLOYMENT 1 0.0003
232 MOOD ALTERED 9 0.0003
233 DYSCHEZIA 1 0.0003
234 THINKING ABNORMAL 6 0.0003
235 SCREAMING 2 0.0003
236 HYPERSOMNIA 9 0.0003
237 PNEUMONIA VIRAL 1 0.0003
238 CUSHINGOID 1 0.0003
239 VULVOVAGINAL DRYNESS 1 0.0003
240 BRADYPHRENIA 2 0.0003
241 LIGAMENT SPRAIN 3 0.0003
242 SKIN INJURY 1 0.0003
243 POTENTIATING DRUG INTERACTION 1 0.0003
244 SLUGGISHNESS 3 0.0003
245 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
246 PRIAPISM 1 0.0003
247 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
248 EXTRASYSTOLES 2 0.0003
249 PRODUCT ODOUR ABNORMAL 3 0.0003
250 DEPRESSIVE SYMPTOM 1 0.0003
251 DRY MOUTH 23 0.0003
252 VOMITING 132 0.0003
253 APPENDICECTOMY 1 0.0003
254 PARALYSIS 4 0.0003
255 DECREASED ACTIVITY 3 0.0003
256 PANIC REACTION 2 0.0003
257 MAJOR DEPRESSION 2 0.0003
258 FOOD INTOLERANCE 1 0.0003
259 ERECTILE DYSFUNCTION 7 0.0003
260 PARADOXICAL DRUG REACTION 1 0.0003
261 BLINDNESS TRANSIENT 2 0.0003
262 PSYCHOTIC DISORDER 8 0.0003
263 FEELING DRUNK 2 0.0003
264 HALLUCINATION 20 0.0003
265 SNORING 1 0.0003
266 BOWEL MOVEMENT IRREGULARITY 2 0.0003
267 LETHARGY 15 0.0003
268 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
269 DYSTONIA 5 0.0003
270 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
271 RHINOVIRUS INFECTION 1 0.0003
272 HEART RATE DECREASED 9 0.0003
273 SEXUAL DYSFUNCTION 3 0.0003
274 BRAIN FOG 4 0.0003
275 CEREBRAL ATROPHY 1 0.0003
276 HYPERPHAGIA 1 0.0003
277 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
278 INTENTIONAL SELF-INJURY 5 0.0002
279 FRUSTRATION TOLERANCE DECREASED 2 0.0002
280 ADVERSE DRUG REACTION 22 0.0002
281 POLYURIA 2 0.0002
282 HYPERAESTHESIA 2 0.0002
283 PHOTOSENSITIVITY REACTION 4 0.0002
284 SOCIAL PROBLEM 1 0.0002
285 MYDRIASIS 3 0.0002
286 PRODUCT DISPENSING ISSUE 1 0.0002
287 HEADACHE 146 0.0002
288 TENSION HEADACHE 1 0.0002
289 PULMONARY FUNCTION TEST DECREASED 1 0.0002
290 BEDRIDDEN 3 0.0002
291 DEPRESSED MOOD 12 0.0002
292 COLD SWEAT 4 0.0002
293 HEAD DISCOMFORT 4 0.0002
294 SEIZURE 26 0.0002
295 FEAR 6 0.0002
296 ANAL INCONTINENCE 2 0.0002
297 PRODUCT AVAILABILITY ISSUE 5 0.0002
298 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
299 ABNORMAL DREAMS 6 0.0002
300 EYE OPERATION 1 0.0002
301 PERSONALITY CHANGE 2 0.0002
302 ROSACEA 1 0.0002
303 SKIN ABRASION 1 0.0002
304 PRODUCT PACKAGING ISSUE 2 0.0002
305 PULSE ABSENT 1 0.0002
306 ENDOMETRIOSIS 1 0.0002
307 RASH VESICULAR 1 0.0002
308 PHARYNGEAL SWELLING 2 0.0002
309 SLEEP DISORDER 14 0.0002
310 DEPRESSION 45 0.0002
311 DYSPHORIA 1 0.0002
312 CORONARY ARTERIAL STENT INSERTION 1 0.0002
313 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
314 ANXIETY 56 0.0002
315 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
316 EUPHORIC MOOD 2 0.0002
317 TRISMUS 1 0.0002
318 HALLUCINATION, VISUAL 4 0.0002
319 OVERWEIGHT 1 0.0002
320 BRUXISM 1 0.0002
321 ASTHENOPIA 1 0.0002
322 AUTISM SPECTRUM DISORDER 1 0.0002
323 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
324 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
325 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
326 DRY EYE 9 0.0002
327 STREPTOCOCCAL INFECTION 1 0.0002
328 CHILLS 21 0.0002
329 INTERMENSTRUAL BLEEDING 1 0.0002
330 THERAPY NON-RESPONDER 8 0.0002
331 IMPAIRED DRIVING ABILITY 2 0.0002
332 SCAB 2 0.0002
333 MUSCLE TWITCHING 4 0.0002
334 PRODUCT DOSE OMISSION ISSUE 51 0.0002
335 SKIN WARM 1 0.0002
336 AMENORRHOEA 3 0.0002
337 DECREASED INTEREST 1 0.0002
338 BRADYKINESIA 1 0.0002
339 SINUS HEADACHE 1 0.0002
340 ODYNOPHAGIA 1 0.0002
341 SYMPTOM RECURRENCE 1 0.0002
342 TYPE 1 DIABETES MELLITUS 1 0.0002
343 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
344 NAUSEA 130 0.0002
345 DRUG WITHDRAWAL SYNDROME 14 0.0002
346 THERAPEUTIC RESPONSE CHANGED 1 0.0002
347 DRUG INTERACTION 25 0.0002
348 GALACTORRHOEA 1 0.0002
349 ILLNESS 16 0.0002
350 HEPATITIS ACUTE 1 0.0002
351 SEDATION 4 0.0002
352 SPEECH DISORDER 8 0.0002
353 SOMNAMBULISM 1 0.0002
354 SINUS DISORDER 3 0.0002
355 CONSTIPATION 33 0.0002
356 APPETITE DISORDER 1 0.0002
357 ADVERSE REACTION 2 0.0002
358 POST-TRAUMATIC STRESS DISORDER 1 0.0001
359 PRODUCT PHYSICAL ISSUE 3 0.0001
360 SINUS CONGESTION 2 0.0001
361 PRODUCT TASTE ABNORMAL 2 0.0001
362 HYPERHIDROSIS 19 0.0001
363 PRODUCT LABEL ISSUE 1 0.0001
364 IMPAIRED GASTRIC EMPTYING 2 0.0001
365 AKATHISIA 2 0.0001
366 DEVICE MECHANICAL ISSUE 2 0.0001
367 GASTROINTESTINAL DISORDER 13 0.0001
368 RESPIRATION ABNORMAL 1 0.0001
369 BLOOD PRESSURE INCREASED 22 0.0001
370 FORMICATION 1 0.0001
371 SEASONAL ALLERGY 2 0.0001
372 HAND FRACTURE 1 0.0001
373 EATING DISORDER 3 0.0001
374 INTENTIONAL DOSE OMISSION 4 0.0001
375 FATIGUE 109 0.0001
376 POOR QUALITY SLEEP 3 0.0001
377 IMPAIRED QUALITY OF LIFE 2 0.0001
378 MENTAL DISORDER 6 0.0001
379 FEELING ABNORMAL 33 0.0001
380 FAECES SOFT 1 0.0001
381 INTENTIONAL UNDERDOSE 1 0.0001
382 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
383 PSYCHIATRIC SYMPTOM 1 0.0001
384 TACHYCARDIA 12 0.0001
385 SKIN HAEMORRHAGE 2 0.0001
386 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
387 DECREASED APPETITE 31 0.0001
388 PRODUCT USE ISSUE 25 0.0001
389 TINNITUS 6 0.0001
390 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
391 DISTURBANCE IN ATTENTION 7 0.0001
392 FOOD ALLERGY 1 0.0001
393 ATRIOVENTRICULAR BLOCK 1 0.0001
394 MULTIPLE ALLERGIES 1 0.0001
395 SENSORY DISTURBANCE 2 0.0001
396 NIGHT SWEATS 4 0.0001
397 MENTAL IMPAIRMENT 3 0.0001
398 MUSCLE TIGHTNESS 2 0.0001
399 DYSKINESIA 5 0.0001
400 SUBSTANCE ABUSE 1 0.0001
401 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
402 HOT FLUSH 9 0.0001
403 SENSATION OF FOREIGN BODY 1 0.0001
404 INADEQUATE ANALGESIA 1 0.0001
405 HYPOPHAGIA 3 0.0001
406 VITAMIN D DECREASED 1 0.0001
407 CARDIAC OPERATION 1 0.0001
408 MUSCLE STRAIN 1 0.0001
409 HYSTERECTOMY 1 0.0001
410 TREMOR 19 0.0001
411 THIRST 2 0.0001
412 LOSS OF LIBIDO 1 0.0001
413 PALPITATIONS 13 0.0001
414 OROPHARYNGEAL DISCOMFORT 1 0.0001
415 RESTLESSNESS 4 0.0001
416 IRON DEFICIENCY ANAEMIA 1 0.0001
417 BLOOD URINE PRESENT 2 0.0001
418 GASTRIC ULCER 2 0.0001
419 INCREASED APPETITE 2 0.0001
420 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
421 BLOOD GLUCOSE DECREASED 5 0.0001
422 LOWER LIMB FRACTURE 2 0.0001
423 ERUCTATION 2 0.0001
424 DIZZINESS POSTURAL 1 0.0001
425 DYSSTASIA 3 0.0001
426 AUTOIMMUNE DISORDER 1 0.0001
427 SKIN FISSURES 2 0.0001
428 COELIAC DISEASE 1 0.0001
429 LOSS OF CONSCIOUSNESS 13 0.0001
430 OVARIAN CYST 1 0.0001
431 APHASIA 3 0.0001
432 TASTE DISORDER 2 0.0001
433 EYELID PTOSIS 1 0.0001
434 SUBARACHNOID HAEMORRHAGE 1 0.0001
435 FEELING HOT 6 0.0001
436 TEMPERATURE INTOLERANCE 1 0.0001
437 VENTRICULAR EXTRASYSTOLES 1 0.0001
438 TENDERNESS 1 0.0001
439 POLLAKIURIA 4 0.0001
440 WEIGHT FLUCTUATION 1 0.0001
441 SCRATCH 1 0.0001
442 INCONTINENCE 1 0.0001
443 RENAL PAIN 1 0.0001
444 HYPOTHYROIDISM 3 0.0001
445 PHARYNGITIS STREPTOCOCCAL 1 0.0001
446 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
447 MENSTRUATION DELAYED 1 0.0001
448 PRODUCT DISPENSING ERROR 2 0.0001
449 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
450 VIRAL INFECTION 3 0.0001
451 GAIT INABILITY 3 0.0001
452 MALNUTRITION 1 0.0001
453 SNEEZING 2 0.0001
454 INTESTINAL PERFORATION 1 0.0001
455 OCULAR DISCOMFORT 1 0.0001
456 HEART RATE IRREGULAR 2 0.0001
457 DIZZINESS 44 0.0001
458 CHEST DISCOMFORT 9 0.0001
459 DERMATITIS CONTACT 1 0.0001
460 ABDOMINAL PAIN UPPER 18 0.0001
461 SKIN IRRITATION 4 0.0001
462 SUICIDE ATTEMPT 5 0.0001
463 BURSITIS 1 0.0001
464 NOCTURIA 1 0.0001
465 PRESYNCOPE 2 0.0001
466 VERTIGO 5 0.0001
467 SMALL INTESTINAL OBSTRUCTION 1 0.0001
468 ILEUS 1 0.0001
469 VISION BLURRED 11 0.0001
470 INJECTION SITE DISCOLOURATION 1 0.0001
471 POISONING 1 0.0001
472 CONDITION AGGRAVATED 24 0.0001
473 PRODUCT COMPLAINT 2 0.0001
474 HAEMATEMESIS 2 0.0001
475 INTRAOCULAR PRESSURE INCREASED 1 0.0001
476 ECZEMA 4 0.0001
477 ANHEDONIA 2 0.0001
478 DISORIENTATION 3 0.0001
479 WEIGHT DECREASED 21 0.0001
480 DEHYDRATION 10 0.0001
481 EYE HAEMORRHAGE 1 0.0001
482 QUALITY OF LIFE DECREASED 1 0.0001
483 SKIN LESION 2 0.0001
484 PERIPHERAL COLDNESS 1 0.0001
485 COMPLETED SUICIDE 6 0.0001
486 ORAL DISCOMFORT 1 0.0001
487 FEELING COLD 2 0.0001
488 HUNGER 1 0.0001
489 ABDOMINAL DISCOMFORT 12 0.0001
490 CARPAL TUNNEL SYNDROME 1 0.0001
491 DYSPEPSIA 7 0.0001
492 PAIN IN JAW 2 0.0001
493 PARAESTHESIA ORAL 1 0.0001
494 HYPOKINESIA 1 0.0001
495 GASTROENTERITIS 1 0.0001
496 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
497 URINARY INCONTINENCE 2 0.0001
498 EPISTAXIS 5 0.0001
499 HYPOAESTHESIA ORAL 1 0.0001
500 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
501 ECONOMIC PROBLEM 1 0.0001
502 ILL-DEFINED DISORDER 4 0.0001
503 PRODUCT USE IN UNAPPROVED INDICATION 16 0.0001
504 THERAPY PARTIAL RESPONDER 1 0.0001
505 PRODUCTIVE COUGH 3 0.0001
506 MOVEMENT DISORDER 2 0.0001
507 DRUG INEFFECTIVE 82 0.0001
508 CARDIAC ARREST 5 0.0001
509 BLOOD PRESSURE DECREASED 4 0.0001
510 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
511 HEPATIC ENZYME INCREASED 4 0.0001
512 SCAR 1 0.0001
513 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
514 MEMORY IMPAIRMENT 8 0.0001
515 DEVICE DEFECTIVE 1 0.0001
516 DELIRIUM 2 0.0001
517 DEVICE USE ERROR 2 0.0001
518 ABDOMINAL DISTENSION 6 0.0001
519 ORTHOSTATIC HYPOTENSION 1 0.0001
520 RASH MACULAR 2 0.0001
521 BRADYCARDIA 3 0.0001
522 LYMPHADENOPATHY 2 0.0001
523 GALLBLADDER DISORDER 1 0.0001
524 GASTROENTERITIS VIRAL 1 0.0001
525 TOOTHACHE 1 0.0001
526 PELVIC PAIN 1 0.0001
527 HYPOTENSION 11 0.0001
528 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
529 BRONCHITIS 4 0.0001
530 CHEST PAIN 10 0.0001
531 NECK PAIN 3 0.0001
532 HYPOCALCAEMIA 1 0.0001
533 DRY SKIN 7 0.0001
534 DRUG INTOLERANCE 5 0.0001
535 CHOKING 1 0.0001
536 DRUG DOSE OMISSION BY DEVICE 4 0.0001
537 HAEMATOCRIT DECREASED 1 0.0001
538 BLOOD PRESSURE ABNORMAL 1 0.0001
539 SYNCOPE 5 0.0000
540 PREGNANCY 1 0.0000
541 DEVICE BREAKAGE 2 0.0000
542 WEIGHT INCREASED 11 0.0000
543 MUSCLE SPASMS 9 0.0000
544 INFLUENZA LIKE ILLNESS 4 0.0000
545 MOUTH ULCERATION 1 0.0000
546 URINARY TRACT INFECTION 8 0.0000
547 JOINT INJURY 1 0.0000
548 IRRITABLE BOWEL SYNDROME 1 0.0000
549 DEVICE LEAKAGE 2 0.0000
550 FAECES DISCOLOURED 1 0.0000
551 BLOOD CREATININE INCREASED 3 0.0000
552 RASH 20 0.0000
553 MALAISE 20 0.0000
554 ASTHENIA 17 0.0000
555 PARAESTHESIA 7 0.0000
556 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
557 PAIN 27 0.0000
558 RENAL DISORDER 2 0.0000
559 COGNITIVE DISORDER 2 0.0000
560 HYPERTENSION 9 0.0000
561 PRODUCT PRESCRIBING ERROR 1 0.0000
562 GAIT DISTURBANCE 8 0.0000
563 URTICARIA 7 0.0000
564 PRURITUS 16 0.0000
565 LOCALISED INFECTION 1 0.0000
566 INJECTION SITE URTICARIA 1 0.0000
567 CARDIOVASCULAR DISORDER 1 0.0000
568 HOSPITALISATION 6 0.0000
569 SINUSITIS 4 0.0000
570 UNRESPONSIVE TO STIMULI 1 0.0000
571 DIARRHOEA 25 0.0000
572 EXPOSURE VIA SKIN CONTACT 1 0.0000
573 DIPLOPIA 1 0.0000
574 GASTRITIS 1 0.0000
575 DERMATITIS ATOPIC 2 0.0000
576 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
577 MENSTRUATION IRREGULAR 1 0.0000
578 PALLOR 1 0.0000
579 ANAPHYLACTIC REACTION 2 0.0000
580 PROCEDURAL PAIN 1 0.0000
581 OXYGEN SATURATION DECREASED 2 0.0000
582 HYPONATRAEMIA 2 0.0000
583 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
584 RED BLOOD CELL COUNT DECREASED 1 0.0000
585 BACK PAIN 8 0.0000
586 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
587 MUSCULOSKELETAL STIFFNESS 3 0.0000
588 COVID-19 6 0.0000
589 DYSPHONIA 2 0.0000
590 SURGERY 2 0.0000
591 RENAL INJURY 1 0.0000
592 HYPOAESTHESIA 5 0.0000
593 BLOOD POTASSIUM DECREASED 1 0.0000
594 HEPATIC FAILURE 1 0.0000
595 DISCOMFORT 2 0.0000
596 EPILEPSY 1 0.0000
597 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
598 OROPHARYNGEAL PAIN 3 0.0000
599 VISUAL IMPAIRMENT 4 0.0000
600 DYSPNOEA 18 0.0000
601 HEAD INJURY 1 0.0000
602 AMNESIA 2 0.0000
603 VISUAL ACUITY REDUCED 1 0.0000
604 ABDOMINAL PAIN 7 0.0000
605 EXPIRED PRODUCT ADMINISTERED 1 0.0000
606 SKIN DISORDER 1 0.0000
607 URINARY RETENTION 1 0.0000
608 EYE PRURITUS 1 0.0000
609 FLUSHING 3 0.0000
610 PYREXIA 10 0.0000
611 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
612 MOBILITY DECREASED 2 0.0000
613 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
614 C-REACTIVE PROTEIN INCREASED 1 0.0000
615 DYSURIA 1 0.0000
616 NASOPHARYNGITIS 5 0.0000
617 HYPERSENSITIVITY 5 0.0000
618 INFLUENZA 3 0.0000
619 EYE SWELLING 1 0.0000
620 DYSARTHRIA 1 0.0000
621 MUSCULAR WEAKNESS 3 0.0000
622 OFF LABEL USE 23 0.0000
623 INJECTION SITE SWELLING 2 0.0000
624 INJECTION SITE PAIN 8 0.0000
625 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
626 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
627 INJECTION SITE HAEMORRHAGE 2 0.0000
628 CARDIAC FAILURE 2 0.0000
629 CONFUSIONAL STATE 4 0.0000
630 TREATMENT FAILURE 2 0.0000
631 ROAD TRAFFIC ACCIDENT 1 0.0000
632 SKIN EXFOLIATION 2 0.0000
633 MYALGIA 4 0.0000
634 HYPOACUSIS 1 0.0000
635 VAGINAL HAEMORRHAGE 1 0.0000
636 SEPTIC SHOCK 1 0.0000
637 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
638 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
639 PRODUCT QUALITY ISSUE 3 0.0000
640 INCORRECT DOSE ADMINISTERED 5 0.0000
641 ARTHRALGIA 9 0.0000
642 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
643 SWELLING 2 0.0000
644 DYSPHAGIA 2 0.0000
645 COMA 1 0.0000
646 RASH ERYTHEMATOUS 1 0.0000
647 HYPOGLYCAEMIA 1 0.0000
648 LUNG DISORDER 1 0.0000
649 PERIPHERAL SWELLING 3 0.0000
650 INFLAMMATION 1 0.0000
651 NERVOUSNESS 1 0.0000
652 RASH PRURITIC 1 0.0000
653 DEPENDENCE 1 0.0000
654 HAEMATOCHEZIA 1 0.0000
655 COUGH 5 0.0000
656 EYE PAIN 1 0.0000
657 CEREBROVASCULAR ACCIDENT 3 0.0000
658 ASTHMA 2 0.0000
659 FLATULENCE 1 0.0000
660 EYE IRRITATION 1 0.0000
661 PRODUCT SUBSTITUTION ISSUE 1 0.0000
662 CATARACT 1 0.0000
663 NO ADVERSE EVENT 3 0.0000
664 THERAPEUTIC RESPONSE DECREASED 1 0.0000
665 INJECTION SITE ERYTHEMA 2 0.0000
666 RHINORRHOEA 1 0.0000
667 ALOPECIA 3 0.0000
668 INJECTION SITE PRURITUS 1 0.0000
669 INJECTION SITE REACTION 1 0.0000
670 BURNING SENSATION 1 0.0000
671 INJURY 1 0.0000
672 INFECTION 2 0.0000
673 UNEVALUABLE EVENT 1 0.0000
674 INJECTION SITE BRUISING 1 0.0000
675 DRUG DEPENDENCE 2 0.0000
676 FALL 4 0.0000
677 DRUG ABUSE 1 0.0000
678 RENAL IMPAIRMENT 1 0.0000
679 BALANCE DISORDER 1 0.0000
680 PRODUCT STORAGE ERROR 1 0.0000
681 INTENTIONAL PRODUCT MISUSE 1 0.0000
682 CARDIAC DISORDER 1 0.0000
683 NEUROPATHY PERIPHERAL 1 0.0000
684 PAIN IN EXTREMITY 3 0.0000
685 HAEMOGLOBIN DECREASED 1 0.0000
686 ERYTHEMA 2 0.0000
687 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
688 HAEMORRHAGE 1 0.0000
689 OVERDOSE 2 0.0000
690 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
691 THROMBOCYTOPENIA 1 0.0000
692 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
693 JOINT SWELLING 1 0.0000
694 EMOTIONAL DISTRESS 1 0.0000
695 TOXICITY TO VARIOUS AGENTS 1 0.0000
696 BLOOD GLUCOSE INCREASED 1 0.0000
697 ANAEMIA 1 0.0000
698 DEATH 2 0.0000